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Abstract
Osteoporosis is associated with low bone mass and microarchitectural deterioration of bone
tissue with clinical manifestation of low trauma fractures. Rheumatoid arthritis (RA) is a risk
factor due to generalized and articular bone loss. This minireview presents past and current
bone mass measurement techniques in RA. These techniques include: plain radiographs,
absorptiometry, quantitative computed tomography (QCT) and ultrasound. The most widely
used technique is dual x-ray absorptiometry (DXA). RA patients have lower bone mass as
compared with normals and substantial bone loss may occur early after the onset of disease.
Measurement of bone mineral density (BMD) at the hand using either DXA or ultrasound
maybe a useful tool in the management of RA patients.
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BMD = bone mineral density; CT = computed tomography; DPA = dual photon absorptiometry; DXA = dual X-ray absorptiometry; kVp = peak
kilovoltage; PA = posterior–anterior; pQCT = peripheral quantitative computed tomography; QCT = quantitative computed tomography; QUS =
quantitative ultrasound; RA = rheumatoid arthritis; SPA = single photon absorptiometry; SXA = single X-ray absorptiometry.
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Introduction
RA is associated with both generalized [1] and articular
bone loss, which could be due to the disease itself, to
inactivity or to treatment with corticosteroids [2]. Bone
loss results in low bone mass and microarchitectural dete-
rioration of bone tissue, leading to diminished biomechani-
cal competence of the skeleton. This condition is often
termed osteopenia or osteoporosis and the clinical conse-
quence is low-trauma or atraumatic fractures, particularly
at the spine, hip and wrist. The most serious fractures are
those of the hip, which contribute substantially to morbid-
ity, mortality and health care costs [3]. Although the patho-
physiology of osteoporosis is multifactorial and complex,
studies have shown that bone mass is the most important
determinant of bone strength and accounts for up to 80%
of its variance [4,5]. Decreased bone mass is therefore a
useful predictor of increased fracture risk [6]. Many
prospective studies have shown that a decrease in bone
density at the spine or hip of one SD increases fracture
risk by a factor of two to three [7–10]. Methods of mea-
suring BMD are therefore pertinent to the detection of
osteopenia, the identification of those individuals at risk of
atraumatic fracture, and the assessment of efficacy of
either prevention or treatment of associated osteoporosis.
Considerable advancement has been made in non-
invasive methods for assessing bone status in the axial
and peripheral skeleton in the past 25 years [11]. Thesehttp://arthritis-research.com/content/2/6/446
methods include photon and X-ray absorptiometry, QCT
and quantitative ultrasound (QUS) [11–13]. The applica-
tion of some of these techniques for longitudinal assess-
ment in RA has been reviewed by Lane et al [14], Deodhar
and Woolf [15] and Verhoeven and Boers [16]. The
choice of site for monitoring depends on two variables:
firstly, the rate of change of bone mass within the skeleton
itself and, secondly, precision of bone density testing at
particular sites. In general, the measured change in bone
density should be 2.8 times the long-term precision error
for the measured variable [17,18]. This review presents
past and present techniques for bone mass measurement
for the serial assessment of bone loss in RA.
Radiographic techniques
Plain radiographs
Conventional radiographs of the peripheral joints are fre-
quently used for the diagnosis and assessment of disease
progression in RA [19,20]. RA can be characterized by the
presence of erosions, periarticular osteoporosis, calcifica-
tion and/or joint space narrowing. To evaluate these
changes, many radiographic scoring systems that require a
single posterior–anterior (PA) film of the hands and wrist
have been developed [21]. However, these methods are
imprecise and coarse for the assessment of osteoporosis.
Also, juxta-articular bone loss precedes the development of
erosions and this does not become apparent radiologically
until a considerable proportion (more than 35%) of the
bone mineral has been lost [22].
Radiographic absorptiometry
Radiographic absorptiometry, the first quantitative tech-
nique to assess integral bone, has recently gained
renewed interest as a simpler, readily available screening
tool [23]. In radiographic absorptiometry, standardized
hand radiographs are taken with an aluminum step-wedge
placed on the film and the imaged is analyzed with an
optical densitometer. The BMD is determined by compari-
son with the defined density of the aluminum step-wedge.
The results are expressed in aluminum equivalent values or
arbitrary units [24]. This is a low-cost and potentially
widely available technique but is it restricted to the appen-
dicular bones such as the metacarpals and phalanges,
which are surrounded by a relatively small amount of soft
tissue. Improvements in obtaining X-rays under standard
conditions and recently developed computer-assisted
methods have reduced operator errors and improved pre-
cision [25,26]. Radiographic absorptiometry seems to be




Single X-ray absorptiometry (SXA), with its high photon
flux, has superseded single photon absorptiometry (SPA).
The replacement of the photon source with an X-ray tube
imparted greater precision and improved spatial resolution
of these systems and reduced examination time [28]. The
method overcomes the problems of radiographic absorp-
tiometry caused by non-uniformity of film sensitivity and
processing. To correct for overlying soft tissue, the
anatomic site at which BMD is being measured has to be
surrounded by either a constant thickness of water, water
bags or water-equivalent moldable materials [13]. SXA
makes possible a quantitative assessment of bone mineral
content only at peripheral sites of the skeleton. At the
radius, BMD measurements are performed at the ultradis-
tal, distal and shaft regions. The precision of 1–2%
depends on the site, with better precision at the shaft
region. The calcaneus is also a site of interest because it
is load bearing and has a high cancellous bone content
[29,30]. SXA has proved to be a valuable method in the
diagnosis of osteoporosis, providing reasonable precision
and low exposure to radiation.
Dual X-ray absorptiometry
DXA was introduced commercially in 1987 as the direct
successor to dual photon absorptiometry (DPA) [31]. The
fundamental physical principle behind DXA is the simulta-
neous measurement of X-rays with two different energies
through the body. The dual X-ray spectrum can be gener-
ated using either K-edge filters or peak kilovoltage (kVp)
switching [32]. The main advantages of an X-ray system
over a DPA radionuclide system are the following: a short-
ened examination time because the X-ray source pro-
duces a much higher photon fluence, greater accuracy
and precision, and the removal of errors due to correc-
tions for source decay [33,34]. A more recent develop-
ment in DXA technology has been the introduction of a
new generation of fan beam scanners such as the Hologic
QDR 4500 (Hologic Inc., Bedford, Massachusetts, USA)
and the Lunar Expert-XL and the Lunar Prodigy (Lunar
Corp., Madison, Wisconsin, USA). Fan beam scanners
perform one or more sweeps across the patient instead of
the two-dimensional raster scan required by pencil beam
geometry. As a result, scan times have been shortened
from 5–10 min to 10–30 s, with a consequent higher
patient throughput. Another advantage of the fan beam
system is the higher image resolution [35,36]. This
permits the easier identification of vertebral structures and
artefacts caused by degenerative disease.
The preferred anatomic sites for DXA measurement of bone
mineral include the lumbar spine (L1–L4), the proximal
femur (neck, trochanter, Ward’s triangle and total hip) and
the whole body, but peripheral sites can also be measured.
DXA has been used in numerous studies involving RA sub-
jects [1,37–40]. Van Schaardenburg et al [40] reported sig-
nificant corticosteroid-induced spinal and femoral bone loss
in patients with RA in a randomized, placebo-controlled trial
on the effects of steroid treatment on bone mass. Disease
duration seems to be an important determinant of bone lossArthritis Research    Vol 2 No 6 Njeh and Genant
in RA. Two longitudinal studies with DXA showed that
patients with RA lose BMD in the lumbar spine and femur
mainly in the early part of their disease [1,38]. Gough et al
[1] also showed that patients with early RA, treated with
1–5 mg of prednisone daily, lost more bone than patients
taking daily doses of more than 5 mg.
Recently, peripheral DXA (pDXA) densitometers especially
designed for forearm or calcaneal measurements have been
introduced and might provide these measurements at a
lower cost [11,41]. For application in RA, hand BMD has
been studied with some interest because it is the principal
site of inflammation and is of prime functional importance
[39,42–44]. Earlier studies did not have dedicated software
to measure hand BMD and thus adapted spine software for
Holigic DXA scanners [39,42] or small-animal software for
Lunar DXA scanners [43]. Hand BMD measurement with
DXA proved highly accurate and reproducible. Hand BMD
was also significantly correlated with BMD at other sites. In
a prospective longitudinal study of hand BMD in patients
with RA, Deodhar et al [45] showed that, despite significant
improvement in clinical and laboratory indices of disease
activity, there was a significant loss of hand BMC during
1 year (5.26% in males, 2.14% in females).
Quantitative computed tomography
QCT can be performed on clinical computed tomography
(CT) scanners to determine in three dimensions the true
volumetric density (mg/cm3) of cancellous or cortical
bone. However, because of the high responsiveness of
vertebral cancellous bone, and its importance in vertebral
strength, QCT has been employed principally to determine
cancellous bone density in the vertebral body [46]. A
spinal QCT examination requires that an external bone
mineral reference phantom be scanned together with the
patient to calibrate the CT number measurements to
bone-equivalent values. QCT’s ability to selectively assess
the metabolically active and structurally important trabecu-
lar bone in the vertebral body results in an excellent ability
to discriminate vertebral fracture and to measure bone
loss, generally with better sensitivity than projectional
methods such as DXA [46,47]. The average cross-sec-
tional bone-loss rate in females from young to old is typi-
cally 1.2% per year when measured with QCT and a little
over half that value when measured with DXA. However,
compared with DXA, QCT scanners are much more
expensive, the precision of BMD measurement is poorer
and the radiation dose to the patient, although acceptable,
is much higher.
To some extent, the high cost of and limited access to
conventional all-purpose CT scanners has prompted the
development of dedicated peripheral QCT (pQCT) instru-
mentation specifically for measurements of purely trabecu-
lar and cortical BMC and BMD in the radius [48,49].
pQCT delivers a lower dose of radiation to the patient
than standard spinal QCT because only the appendicular
skeleton is irradiated. Unlike SPA or SXA, pQCT uses a
transaxial image to allow separate measurement of the
true volumetric density (mg/cm3) and cross-sectional area
of trabecular and cortical bone without superposition of
other tissues, and provides exact three-dimensional local-
ization of the target volume. The ability to measure the
metabolically more active trabecular bone and determine
geometric parameters related to the cortical shell such as
moment of inertia and mean thickness, as well as the ease
of use, make pQCT an interesting alternative to SPA or
SXA [11,50]. QCT has been used to study bone loss in
RA subjects [51–53] in whom significant loss was
observed in trabecular bone compared with cortical bone.
Ultrasound
QUS has been established as another modality in the
assessment of skeletal status. The advantages of QUS
include the fact that the equipment is inexpensive, small
and portable, and does not involve the use of ionizing radi-
ation. Moreover, indirect studies and/or studies in vitro
have suggested that ultrasound might give information not
only about bone density but also about architecture and
elasticity [12,54–57]. These benefits, combined with clini-
cal results showing good diagnostic sensitivity for fracture
discrimination, have encouraged further basic investiga-
tion and commercial development. Several manufacturers
have developed different QUS systems since the late
1980s. Most of the commercial QUS systems measure
the calcaneus submerged in a water bath or with ultra-
sonic gel as couplant and a fixed single-point transmission
transducer system. Recent developments include cal-
caneal transmission imaging, phalangeal, tibial and multi-
site measuring devices [58].
Bone tissue can be characterized in terms of speed of
sound (SOS) and broadband ultrasound attenuation
(BUA). These parameters are significantly positively corre-
lated with BMD in vivo. Site-matched comparisons of
BMD and QUS measurements have produced correla-
tions of approx. 0.7–0.90 [12]. Both cross-sectional and
prospective studies have demonstrated that QUS can be
used to discriminate normal from osteoporotic subjects
nearly as effectively as traditional bone densitometry
approaches [55,59–61]. The ability of QUS to discrimi-
nate between normal and osteoporotic patients is partly
independent of BMD in some cases [60]. There is a
growing interest in the use of phalangeal ultrasound [62]
and calcaneal ultrasound [63–66] to assess bone status
in RA patients. Martin et al [64] demonstrated a significant
decrease in both ultrasound attenuation (31.7%) and
velocity (6.6%) measured at the calcaneus of RA patients
in comparison with controls. In studies by Daens et al [65]
and Blanckaert et al [66], QUS performed similarly to
BMD measured at the spine and femur in evaluating
glucocorticoid-induced osteoporosis.http://arthritis-research.com/content/2/6/446
Conclusion
The most prevalent methods for assessing the skeleton
are SXA, DXA, QCT and QUS; these have been applied
successfully in the measurement of bone loss in RA.
Patients with RA have lower bone mass in the appendicu-
lar and axial skeleton than normals.
Longitudinal densitometry studies demonstrate that
substantial loss of bone mass can occur early in the first
year after the onset of disease.
The hand is an area of considerable disease activity;
therefore measurement of BMD at the hand with either
DXA or ultrasound may be a useful tool in the manage-
ment of RA patients.
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